Navigation Links
Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimer's Disease and Other Proteinopathies
Date:10/26/2011

is focused on developing next generation antibody therapeutics. Its most advanced internal candidate is IN-N01-OX2, a humanized monoclonal antibody drug conjugate that has potential applications to treat Alzheimer's disease, Early-Onset Familial Alzheimer's disease, cerebral angiopathy, age-related macular degeneration, glaucoma and traumatic brain injury. In addition, IN-N01-OX2 has potential applications for in vivo imaging of beta amyloid in the brain.  The company's RECALL-VAX technology is a proprietary Alzheimer's vaccine with therapeutic and prophylactic potential.

Safe Harbor Statement Regarding Forward-Looking Statements:

The statements in this release and oral statements made by representatives of Intellect relating to matters that are not historical facts (including, without limitation, those  regarding future performance or financial results, the timing or potential outcomes of research collaborations or clinical trials, any market that might develop for any of Intellect's product candidates and the sufficiency of Intellect's cash and other capital resources) are forward-looking statements that involve risks and uncertainties, including, but not limited to, the likelihood that actual performance or results could materially differ, that future research will prove successful, the likelihood that any product in the research pipeline will receive regulatory approval in the United States or abroad, or Intellect's ability to fund such efforts with or without partners. Intellect undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statements should be read in conjunction with the additional risks and uncertainties detailed in Intellect's filings with the Securities and Exchange Commission, including those factors discussed under the caption "Risk Factors" in Intel
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intellect Neurosciences Issues Letter to Shareholders
2. Intellect Neurosciences CEO to be Featured on Wall Street Reporter
3. ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreichs Ataxia
4. IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics, Inc.
5. PILMA Vows to Redouble Support for Increased Protections Against Intellectual Property Theft
6. Dehaier Strengthens Intellectual Property Portfolio
7. NMT Medical, Inc. Adds Intellectual Property to Its Sealed Bid Sale of Friday, June 10, 2011 at Twelve OClock Noon
8. GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling
9. Inovio Pharmaceuticals Market-Leading Intellectual Property Recognized by MDB Capital Award
10. NMT Medical, Inc. Sealed Bid Sale of its Intellectual Property to Take Place Friday, June 10, 2011 at Twelve OClock Noon
11. Software Development Firms New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... SAN JOSE, Calif. , Sept. 17, 2014 ... as a laureate of The Tech Awards 2014, one ... benefit humanity and spark global change. The Tech Awards, a ... by Applied Materials, Inc., selected Gradian as one of two ... - http://photos.prnewswire.com/prnh/20140917/146680 Gradian equips hospitals ...
(Date:9/17/2014)... -- , Glenmark,s first in ... in a Phase 2a proof of concept study in ... Glenmark Pharmaceuticals today announced that its first in ... 17536 has shown positive data in a Phase 2a ... conducted on 138 patients in Europe ...
(Date:9/17/2014)... , Sept. 17, 2014  Millions of people suffer ... disc disease. Recently the FDA approved the ... disc, an innovative implant device developed by Spinal Kinetics, which ... in neck and or arm pain. Hospital for Special Surgery ... the only hospital in New York City ...
Breaking Medicine Technology:Gradian Health Systems Named A 2014 Laureate of The Tech Awards 2Gradian Health Systems Named A 2014 Laureate of The Tech Awards 3Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 3Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2
... 10, 2011 Cephalon, Inc. (Nasdaq: CEPH ) ... percent increase compared to net sales of $2.152 billion for ... $5.66.  Excluding amortization expense and certain other items, adjusted net ... percent increase over the previous year.  This exceeded the company,s ...
... Medicare beneficiaries are reporting problems receiving medically required ... 2011 implementation of Medicare,s "competitive" bidding program in Cleveland ... than 640,000 seniors and people living with disabilities in ... The bidding program began in nine areas on ...
Cached Medicine Technology:Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 2Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 3Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 4Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 5Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 6Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 7Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 8Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 9Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 10Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 11Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 12Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 13Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 14Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 15Seniors in Ohio Report Problems With Access to Home Medical Equipment and Services Under Controversial Medicare Bidding System 2Seniors in Ohio Report Problems With Access to Home Medical Equipment and Services Under Controversial Medicare Bidding System 3
(Date:9/17/2014)... 2014 (HealthDay News) -- Social networking sites can help ... For people who are obese, sites like Twitter and ... support from doctors as well as peers, researchers found. ... methods is that it offers the potential to be ... when compared to traditional approaches," the study,s lead author, ...
(Date:9/17/2014)... Bioluminescence, nanoparticles, gene manipulation these sound like ... in fact, they are components of an exciting ... In preclinical animal models of metastatic prostate cancer, ... VCU Institute of Molecular Medicine and Johns Hopkins ... molecular imaging approach that could revolutionize doctors, ability ...
(Date:9/17/2014)... Dallas, TX (PRWEB) September 17, 2014 ... they were recently granted several awards for their top-notch ... regarding patient experience, orthopedic care and GYN surgery. , ... Patient Safety Excellence Award™. They have received this award ... ranked among the top 5 percent in the nation ...
(Date:9/17/2014)... N.J. (PRWEB) September 17, 2014 ... advanced delivery technologies and development solutions for drugs, ... launch of OptiPact™, an integrated service and technology ... compaction, and provided from the company’s 450,000 sq. ... describes Catalent’s ability to integrate optimal formulation, development, ...
(Date:9/17/2014)... Dennis Thompson ... News) -- Exposure in the womb to household chemicals ... of developing asthma, Columbia University researchers reported in a ... increased risk of developing asthma between age 5 and ... high levels of two phthalates (pronounced thal-ates), the researchers ...
Breaking Medicine News(10 mins):Health News:Social Networking Sites Can Help Obese Lose Weight: Study 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 3Health News:North Central Surgical Center Receives Several Accolades 2Health News:New OptiPact™ Technology Introduced by Catalent 2Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 2Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 3Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 4
... Consumption of supplemental zinc is associated with an increased ... of data from the Health Professionals Follow-up Study. ,The ... soft tissues. However, studies of the effect of zinc ... 46,000 men followed in the health professionals study, there ...
... leprosy, are the world’s most neglected diseases along ... African trypanosomiasis)and Chagas disease, that afflict the deeply ... of the global disease burden however ironically, a ... to these diseases.// , ,In a laudable initiative, ...
... than people who speak English, scientists said on Monday, ... the brain processes language. ,Unlike English speakers, who use ... scientists at the Wellcome Trust research charity in Britain ... to interpret variations in sounds in Mandarin.// ,"We ...
... problem for doctors, but what do they do when the ... to answer in a new study published in this month’s ... years worth of hospital records in Galveston, Texas, identified several ... follow when man bites man. ,The study uncovered 40 human ...
... one to suspect health problems, including heart disease. ... are at higher risk for heart attacks. ,A sore ... notes the Academy of General Dentistry. There's also a ... patients with heart conditions by diagnosing dental problems// that ...
... turn to complementary and alternative medicine, researchers have ... associated with such use. ,In this study, ... enrolled in the HIV Cost and Services Utilization ... conventional HIV care, researchers determined demographic and clinical ...
Cached Medicine News:Health News:ICMR along with other International Research organisation with drug development for Neglected Diseases, 2Health News:,Alternative Therapy in HIV Patients 2
... water perfused manometric catheters for ... diagnostic tests. All Medtronic Water ... clear, medical grade PVC tubing. ... esophagus you will find a ...
Each solid state catheter kit below is supplied with adapter cable(s) for Polygraf ID and a Manometric Calibrator....
... Medtronic offers a family of single-use ... and convenience for you. This single-use catheter ... from the risk of infection and, because ... for patient care., ,We have water ...
... of single-use products to promote safety for ... single-use catheter reduces cross-contamination and helps protect ... and, because cleaning is eliminated, you have ... have water perfused manometric catheters for esophageal, ...
Medicine Products: